{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:21:44Z","timestamp":1792002104146,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Wuhan Municipal and Health Research Fund","award":["WZ24B39"],"award-info":[{"award-number":["WZ24B39"]}]},{"name":"Wuhan Municipal and Health Research Fund","award":["WZ24B39"],"award-info":[{"award-number":["WZ24B39"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-05685-4","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T14:51:16Z","timestamp":1745333476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Epimedin B protects against bone loss and inflammation in diabetic osteoporosis rats by regulating OPG\/RANKL pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Xianmei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"5685_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"5685_CR2","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1210\/jc.2017-00042","volume":"102","author":"SA Paschou","year":"2017","unstructured":"Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 diabetes and osteoporosis: A guide to optimal management. J Clin Endocrinol Metab. 2017;102(10):3621\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"5685_CR3","doi-asserted-by":"publisher","first-page":"e0254451","DOI":"10.1371\/journal.pone.0254451","volume":"16","author":"HH Lin","year":"2021","unstructured":"Lin HH, Hsu HY, Tsai MC, Hsu LY, Chien KL, Yeh TL. Association between type 2 diabetes and osteoporosis risk: A representative cohort study in Taiwan. PLoS ONE. 2021;16(7):e0254451.","journal-title":"PLoS ONE"},{"issue":"1","key":"5685_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-022-01260-8","volume":"23","author":"X Liu","year":"2023","unstructured":"Liu X, Chen F, Liu L, Zhang Q. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr Disord. 2023;23(1):1.","journal-title":"BMC Endocr Disord"},{"key":"5685_CR5","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.2147\/DMSO.S372348","volume":"15","author":"T Li","year":"2022","unstructured":"Li T, Hu L, Yin XL, Zou Y, Fu HY, Li HL. Prevalence and risk factors of osteoporosis in patients with type 2 diabetes mellitus in Nanchang (China): A retrospective cohort study. Diabetes Metab Syndr Obes. 2022;15:3039\u201348.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"5685_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a bayesian network meta-analysis. Br Med Bull. 2022;143(1):46\u201356.","journal-title":"Br Med Bull"},{"issue":"3","key":"5685_CR7","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/ijms16035452","volume":"16","author":"V Conti","year":"2015","unstructured":"Conti V, Russomanno G, Corbi G, Toro G, Simeon V, Filippelli W, et al. A polymorphism at the translation start site of the vitamin D receptor gene is associated with the response to anti-osteoporotic therapy in postmenopausal women from Southern Italy. Int J Mol Sci. 2015;16(3):5452\u201366.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5685_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a bayesian network meta-analysis. J Orthop Surg Res. 2021;16(1):533.","journal-title":"J Orthop Surg Res"},{"issue":"9","key":"5685_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1080\/14712598.2019.1618266","volume":"19","author":"S Mohsin","year":"2019","unstructured":"Mohsin S, Baniyas MM, AlDarmaki RS, Tekes K, Kal\u00e1sz H, Adeghate EA. An update on therapies for the treatment of diabetes-induced osteoporosis. Expert Opin Biol Ther. 2019;19(9):937\u201348.","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"5685_CR10","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","volume":"5","author":"S Khosla","year":"2017","unstructured":"Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5(11):898\u2013907.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"5685_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41413-022-00219-8","volume":"10","author":"S Bolamperti","year":"2022","unstructured":"Bolamperti S, Villa I, Rubinacci A. Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Res. 2022;10(1):48.","journal-title":"Bone Res"},{"issue":"7674","key":"5685_CR12","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/550S15a","volume":"550","author":"C Brown","year":"2017","unstructured":"Brown C. Staying strong. Nature. 2017;550(7674):S15\u20137.","journal-title":"Nature"},{"issue":"1","key":"5685_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1272\/jnms.77.4","volume":"77","author":"H Orimo","year":"2010","unstructured":"Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch. 2010;77(1):4\u201312.","journal-title":"J Nippon Med Sch"},{"key":"5685_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cytogfr.2019.09.001","volume":"49","author":"C Licini","year":"2019","unstructured":"Licini C, Vitale-Brovarone C, Mattioli-Belmonte M. Collagen and non-collagenous proteins molecular crosstalk in the pathophysiology of osteoporosis. Cytokine Growth Factor Rev. 2019;49:59\u201369.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"5685_CR15","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1210\/endo.141.9.7634","volume":"141","author":"N Udagawa","year":"2000","unstructured":"Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, et al. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology. 2000;141(9):3478\u201384.","journal-title":"Endocrinology"},{"key":"5685_CR16","doi-asserted-by":"publisher","first-page":"1370900","DOI":"10.3389\/fphar.2024.1370900","volume":"15","author":"G Cao","year":"2024","unstructured":"Cao G, Hu S, Ning Y, Dou X, Ding C, Wang L, et al. Traditional Chinese medicine in osteoporosis: from pathogenesis to potential activity. Front Pharmacol. 2024;15:1370900.","journal-title":"Front Pharmacol"},{"issue":"2","key":"5685_CR17","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/jcp.26084","volume":"233","author":"F Song","year":"2018","unstructured":"Song F, Wei C, Zhou L, Qin A, Yang M, Tickner J, et al. Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades. J Cell Physiol. 2018;233(2):1723\u201335.","journal-title":"J Cell Physiol"},{"issue":"3","key":"5685_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.bcp.2010.04.014","volume":"80","author":"JW Lee","year":"2010","unstructured":"Lee JW, Kobayashi Y, Nakamichi Y, Udagawa N, Takahashi N, Im NK, et al. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Biochem Pharmacol. 2010;80(3):352\u201361.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"5685_CR19","doi-asserted-by":"publisher","first-page":"27470","DOI":"10.3390\/ijms161126039","volume":"16","author":"T Wang","year":"2015","unstructured":"Wang T, Liu Q, Zhou L, Yuan JB, Lin X, Zeng R, et al. Andrographolide inhibits Ovariectomy-Induced bone loss via the suppression of RANKL signaling pathways. Int J Mol Sci. 2015;16(11):27470\u201381.","journal-title":"Int J Mol Sci"},{"key":"5685_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1472-6882-14-35","volume":"14","author":"SW Choi","year":"2014","unstructured":"Choi SW, Park KI, Yeon JT, Ryu BJ, Kim KJ, Kim SH. Anti-osteoclastogenic activity of Matairesinol via suppression of p38\/ERK-NFATc1 signaling axis. BMC Complement Altern Med. 2014;14:35.","journal-title":"BMC Complement Altern Med"},{"issue":"10","key":"5685_CR21","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.bcp.2013.09.009","volume":"86","author":"M Satu\u00e9","year":"2013","unstructured":"Satu\u00e9 M, Arriero Mdel M, Monjo M, Ramis JM. Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells. Biochem Pharmacol. 2013;86(10):1476\u201386.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"5685_CR22","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.3390\/molecules15117861","volume":"15","author":"SC Sze","year":"2010","unstructured":"Sze SC, Tong Y, Ng TB, Cheng CL, Cheung HP. Herba epimedii: anti-oxidative properties and its medical implications. Molecules. 2010;15(11):7861\u201370.","journal-title":"Molecules"},{"issue":"6","key":"5685_CR23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/bcpt.13657","volume":"129","author":"X Diao","year":"2021","unstructured":"Diao X, Wang L, Zhou Y, Bi Y, Zhou K, Song L. The mechanism of Epimedin B in treating osteoporosis as revealed by RNA sequencing-based analysis. Basic Clin Pharmacol Toxicol. 2021;129(6):450\u201361.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"5685_CR24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.diabet.2010.07.001","volume":"36","author":"C Garcia","year":"2010","unstructured":"Garcia C, Feve B, Ferr\u00e9 P, Halimi S, Baizri H, Bordier L, et al. Diabetes and inflammation: fundamental aspects and clinical implications. Diabetes Metab. 2010;36(5):327\u201338.","journal-title":"Diabetes Metab"},{"issue":"5","key":"5685_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11914-015-0286-8","volume":"13","author":"H Jiao","year":"2015","unstructured":"Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep. 2015;13(5):327\u201335.","journal-title":"Curr Osteoporos Rep"},{"key":"5685_CR26","first-page":"p125705","volume":"2013","author":"MN Weitzmann","year":"2013","unstructured":"Weitzmann MN. The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica (Cairo). 2013;2013:p125705.","journal-title":"Scientifica (Cairo)"},{"key":"5685_CR27","doi-asserted-by":"publisher","first-page":"109657","DOI":"10.1016\/j.fsi.2024.109657","volume":"150","author":"L Liu","year":"2024","unstructured":"Liu L, Zhong Y, Zheng T, Zhao J, Ding S, Lv J, et al. Epimedin B exerts an anti-inflammatory effect by regulating the MAPK\/NF-\u03baB\/NOD-like receptor signalling pathways. Fish Shellfish Immunol. 2024;150:109657.","journal-title":"Fish Shellfish Immunol"},{"key":"5685_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.biopha.2017.08.098","volume":"95","author":"S Gheibi","year":"2017","unstructured":"Gheibi S, Kashfi K, Ghasemi A. A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother. 2017;95:605\u201313.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5685_CR29","first-page":"641","volume":"42","author":"S Liu","year":"2022","unstructured":"Liu S, Liu Q, Peng Q, Zhang Y, Wang J. [Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats]. Nan Fang Yi Ke Da Xue Xue Bao. 2022;42(5):641\u20138.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"5685_CR30","doi-asserted-by":"publisher","first-page":"113955","DOI":"10.1016\/j.biopha.2022.113955","volume":"156","author":"M Zhang","year":"2022","unstructured":"Zhang M, Hu ZF, Dong XL, Chen WF. Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson\u2019s disease: GPER as a potential target. Biomed Pharmacother. 2022;156:113955.","journal-title":"Biomed Pharmacother"},{"issue":"336","key":"5685_CR31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.morpho.2017.07.175","volume":"102","author":"R Rieger","year":"2018","unstructured":"Rieger R, Auregan JC, Hoc T. Micro-finite-element method to assess elastic properties of trabecular bone at micro- and macroscopic level. Morphologie. 2018;102(336):12\u201320.","journal-title":"Morphologie"},{"issue":"1","key":"5685_CR32","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1038\/s41598-021-83263-4","volume":"11","author":"Y Xu","year":"2021","unstructured":"Xu Y, Wu Q. Trends in osteoporosis and mean bone density among type 2 diabetes patients in the US from 2005 to 2014. Sci Rep. 2021;11(1):3693.","journal-title":"Sci Rep"},{"issue":"9","key":"5685_CR33","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00198-017-4097-x","volume":"28","author":"VN Shah","year":"2017","unstructured":"Shah VN, Harrall KK, Shah CS, Gallo TL, Joshee P, Snell-Bergeon JK, et al. Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature. Osteoporos Int. 2017;28(9):2601\u201310.","journal-title":"Osteoporos Int"},{"issue":"5","key":"5685_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","volume":"27","author":"L Ma","year":"2012","unstructured":"Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z, et al. Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012;27(5):319\u201332.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"5685_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1124\/mol.109.057877","volume":"77","author":"JH Lee","year":"2010","unstructured":"Lee JH, Jin H, Shim HE, Kim HN, Ha H, Lee ZH. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol Pharmacol. 2010;77(1):17\u201325.","journal-title":"Mol Pharmacol"},{"key":"5685_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jep.2016.05.025","volume":"189","author":"ND Zhang","year":"2016","unstructured":"Zhang ND, Han T, Huang BK, Rahman K, Jiang YP, Xu HT, et al. Traditional Chinese medicine formulas for the treatment of osteoporosis: implication for antiosteoporotic drug discovery. J Ethnopharmacol. 2016;189:61\u201380.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"5685_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1381612822666151112145907","volume":"22","author":"L Wang","year":"2016","unstructured":"Wang L, Li Y, Guo Y, Ma R, Fu M, Niu J, et al. Herba epimedii: an ancient Chinese herbal medicine in the prevention and treatment of osteoporosis. Curr Pharm Des. 2016;22(3):328\u201349.","journal-title":"Curr Pharm Des"},{"key":"5685_CR38","doi-asserted-by":"crossref","unstructured":"Noh JY, Yang Y, Jung H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci, 2020. 21(20).","DOI":"10.3390\/ijms21207623"},{"issue":"1","key":"5685_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/etm.2014.2071","volume":"9","author":"Y Lv","year":"2015","unstructured":"Lv Y, Wang G, Xu W, Tao P, Lv X, Wang Y. Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear \u039aB ligand. Exp Ther Med. 2015;9(1):143\u20136.","journal-title":"Exp Ther Med"},{"key":"5685_CR40","doi-asserted-by":"publisher","first-page":"108570","DOI":"10.1016\/j.biopha.2019.01.031","volume":"115","author":"CJ Guo","year":"2019","unstructured":"Guo CJ, Xie JJ, Hong RH, Pan HS, Zhang FG, Liang YM. Puerarin alleviates streptozotocin (STZ)-induced osteoporosis in rats through suppressing inflammation and apoptosis via HDAC1\/HDAC3 signaling. Biomed Pharmacother. 2019;115:108570.","journal-title":"Biomed Pharmacother"},{"key":"5685_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.biopha.2018.08.131","volume":"108","author":"H Xie","year":"2018","unstructured":"Xie H, Wang Q, Zhang X, Wang T, Hu W, Manicum T, et al. Possible therapeutic potential of Berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis. Biomed Pharmacother. 2018;108:280\u20137.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"5685_CR42","doi-asserted-by":"publisher","first-page":"e1700578","DOI":"10.1002\/cbdv.201700578","volume":"15","author":"Y Guo","year":"2018","unstructured":"Guo Y, Wang X, Gao J. Simultaneous Preparation and comparison of the osteogenic effects of Epimedins A - C and Icariin from Epimedium Brevicornu. Chem Biodivers. 2018;15(4):e1700578.","journal-title":"Chem Biodivers"},{"issue":"6","key":"5685_CR43","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.stem.2017.02.009","volume":"20","author":"TH Ambrosi","year":"2017","unstructured":"Ambrosi TH, Scialdone A, Graja A, Gohlke S, Jank AM, Bocian C, et al. Adipocyte accumulation in the bone marrow during obesity and aging impairs stem Cell-Based hematopoietic and bone regeneration. Cell Stem Cell. 2017;20(6):771\u2013e7846.","journal-title":"Cell Stem Cell"},{"issue":"5","key":"5685_CR44","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1210\/er.2018-00138","volume":"40","author":"ZL Sebo","year":"2019","unstructured":"Sebo ZL, Rendina-Ruedy E, Ables GP, Lindskog DM, Rodeheffer MS, Fazeli PK, et al. Bone marrow adiposity: basic and clinical implications. Endocr Rev. 2019;40(5):1187\u2013206.","journal-title":"Endocr Rev"},{"issue":"3","key":"5685_CR45","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11914-018-0442-z","volume":"16","author":"J Bukowska","year":"2018","unstructured":"Bukowska J, Frazier T, Smith S, Brown T, Bender R, McCarthy M, et al. Bone marrow adipocyte developmental origin and biology. Curr Osteoporos Rep. 2018;16(3):312\u20139.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"5685_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","volume":"9","author":"CMO Volpe","year":"2018","unstructured":"Volpe CMO, Villar-Delfino PH, Dos PMF, Anjos JA, Nogueira-Machado. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.","journal-title":"Cell Death Dis"},{"issue":"11","key":"5685_CR47","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/jcp.24626","volume":"229","author":"EJ Lee","year":"2014","unstructured":"Lee EJ, Song DH, Kim YJ, Choi B, Chung YH, Kim SM, et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. J Cell Physiol. 2014;229(11):1744\u201352.","journal-title":"J Cell Physiol"},{"issue":"3","key":"5685_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","volume":"5","author":"BF Boyce","year":"2007","unstructured":"Boyce BF, Xing L. The RANKL\/RANK\/OPG pathway. Curr Osteoporos Rep. 2007;5(3):98\u2013104.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"5685_CR49","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13052-019-0748-1","volume":"45","author":"P Karalazou","year":"2019","unstructured":"Karalazou P, Ntelios D, Chatzopoulou F, Fragou A, Taousani M, Mouzaki K, et al. OPG\/RANK\/RANKL signaling axis in patients with type I diabetes: associations with parathormone and vitamin D. Ital J Pediatr. 2019;45(1):161.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"5685_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5312\/wjo.v4.i4.207","volume":"4","author":"H Yasuda","year":"2013","unstructured":"Yasuda H. RANKL, a necessary chance for clinical application to osteoporosis and cancer-related bone diseases. World J Orthop. 2013;4(4):207\u201317.","journal-title":"World J Orthop"},{"issue":"5","key":"5685_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/jdi.12632","volume":"8","author":"Y Mitama","year":"2017","unstructured":"Mitama Y, Fujiwara S, Yoneda M, Kira S, Kohno N. Association of type 2 diabetes and an inflammatory marker with incident bone fracture among a Japanese cohort. J Diabetes Investig. 2017;8(5):709\u201315.","journal-title":"J Diabetes Investig"},{"issue":"6","key":"5685_CR52","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1172\/JCI87430","volume":"126","author":"J Iqbal","year":"2016","unstructured":"Iqbal J, Yuen T, Sun L, Zaidi M. From the gut to the strut: where inflammation reigns, bone abstains. J Clin Invest. 2016;126(6):2045\u20138.","journal-title":"J Clin Invest"},{"issue":"4","key":"5685_CR53","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.bbrc.2018.10.007","volume":"505","author":"C Lei","year":"2018","unstructured":"Lei C, Xueming H, Ruihang D. MLN64 deletion suppresses RANKL-induced osteoclastic differentiation and attenuates diabetic osteoporosis in streptozotocin (STZ)-induced mice. Biochem Biophys Res Commun. 2018;505(4):1228\u201335.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-05685-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-05685-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:10:23Z","timestamp":1745334623000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-05685-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5685"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-05685-4","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were reviewed and approved by Wuhan Myhalic Biotechnology Co., Ltd (approval number: HLK-202309244; approval date: September 15, 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}